CVE-2026-105704SourceCodester Drug Recommendation System Auth Guard improper authentication
Updated under an hour ago ()
Does this affect you?
It affects SourceCodester Drug Recommendation System. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.40%, higher than 32% of scored CVEs.
Do this next
Free account, 1 product
A vulnerability was identified in SourceCodester Drug Recommendation System 1.0. This affects an unknown function of the component Auth Guard. Such manipulation of the argument user_id leads to improper authentication. The attack can be executed remotely. The exploit is publicly available and might be used.
- CVSS
- 7.3 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L/E:P/RL:X/RC:R
- Weakness (CWE)
- CWE-287
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.40% (percentile 32)
- Assigned by
- VulDB
- NVD analysis
- Deferred
- Record last updated
- Oct 6, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
SourceCodester Drug Recommendation System sourcecodester:drug_recommendation_system | 1.0 | CNA record |
References
- https://vuldb.com/vuln/413697vdb-entry, technical-description
- https://vuldb.com/vuln/413697/ctisignature, permissions-required
- https://vuldb.com/cve/CVE-2026-105704third-party-advisory
- https://vuldb.com/submit/992051third-party-advisory
- https://github.com/hackliu/Vulnerability-Reports/blob/master/Drug-Recommender-Web-App/VULN-02-Broken-Access-Control.mdexploit
- https://www.sourcecodester.com/product
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.